propranolol has been researched along with Palmoplantaris Pustulosis in 42 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| " There are some reports have shown that curcumin, the major component of curcuma, has a good curative effect on psoriasis, but the mechanism is still unknown, so the present study was designed to investigate the effect of curcuma's extraction on psoriasis-like mouse, and to explore the mechanisms of therapy." | 7.96 | Curcuma's extraction attenuates propranolol-induced psoriasis like in mice by inhibition of keratin, proliferating cell nuclear antigen and toll-like receptor expression. ( He, D; Li, JQ; She, SY; Tong, RS; Zhang, SH; Zhong, ZD, 2020) |
| "Astilbin has anti-inflammatory and immunoregulatory effects, and is frequently used in prescriptions treating psoriasis; however, the mechanism remains to be fully elucidated." | 7.88 | Astilbin emulsion improves guinea pig lesions in a psoriasis-like model by suppressing IL-6 and IL-22 via p38 MAPK. ( Lu, C; Xiao, Z; Yu, J; Zhang, Y; Zhao, R, 2018) |
| " The back of the ears of individual guinea pigs was topically exposed to 5% propranolol emulsion to induce psoriasis-like lesions and randomly treated topically with phosphate buffered saline (PBS), hydrocortisone butyrate, or different doses of anti-FGF10." | 7.80 | Topical application of a new monoclonal antibody against fibroblast growth factor 10 (FGF 10) mitigates propranolol-induced psoriasis-like lesions in guinea pigs. ( Dong, YY; Guan, LL; Li, HY; Li, XK; Liu, XM; Mmi, XG; Wang, FW; Wang, N; Wang, YF; Xia, JX; Yang, J; Yao, N, 2014) |
| "A 25-year-old male developed sinus tachycardia after given clozapine for treatment-resistant psychosis in schizophrenia." | 7.78 | [Treatment of clozapine-induced tachycardia with propranolol complicated by psoriasis]. ( Bosch, TM; Hovens, JE; Mookhoek, EJ; van Dam, D, 2012) |
| " PHA-stimulated T cells were additionally treated with psoriasis-provoking drugs (lithium, chloroquine, propranolol and ethanol) and the two immunosuppressive drugs cyclosporin A and FK 506." | 7.69 | Tyrosine phosphorylation in psoriatic T cells is modulated by drugs that induce or improve psoriasis. ( Goos, M; Mertins, K; Nussbaum, G; Ockenfels, HM; Schultewolter, T; Wagner, SN, 1995) |
| "An 80-year-old man who had had plaque-type psoriasis for 40 years experienced a rapid onset of generalized pustular psoriasis three days after initiation of propranolol hydrochloride therapy." | 7.67 | Generalized pustular psoriasis provoked by propranolol. ( Farber, EM; Hu, CH; Miller, AC; Peppercorn, R, 1985) |
| "Propranolol, 0." | 5.29 | Psoriasis-like lesions in guinea pigs receiving propranolol. ( Altug, T; Büyükdevrim, S; Gürel, N; Tüzün, B; Tüzün, Y; Tüzüner, N, 1993) |
| "Drugs that have been associated with the precipitation or exacerbation of psoriasis include lithium, beta adrenergic receptor blocking agents, and antimalarials." | 4.77 | Drugs in exacerbation of psoriasis. ( Abel, EA; DiCicco, LM; Farber, EM; Fraki, JE; Orenberg, EK, 1986) |
| " There are some reports have shown that curcumin, the major component of curcuma, has a good curative effect on psoriasis, but the mechanism is still unknown, so the present study was designed to investigate the effect of curcuma's extraction on psoriasis-like mouse, and to explore the mechanisms of therapy." | 3.96 | Curcuma's extraction attenuates propranolol-induced psoriasis like in mice by inhibition of keratin, proliferating cell nuclear antigen and toll-like receptor expression. ( He, D; Li, JQ; She, SY; Tong, RS; Zhang, SH; Zhong, ZD, 2020) |
| "Astilbin has anti-inflammatory and immunoregulatory effects, and is frequently used in prescriptions treating psoriasis; however, the mechanism remains to be fully elucidated." | 3.88 | Astilbin emulsion improves guinea pig lesions in a psoriasis-like model by suppressing IL-6 and IL-22 via p38 MAPK. ( Lu, C; Xiao, Z; Yu, J; Zhang, Y; Zhao, R, 2018) |
| " The in vivo anti-psoriasis effects of ZnPc-F7-PDT were evaluated using a mouse vagina model, a propranolol-induced cavy psoriasis model and an imiquimod (IMQ)-induced nude mouse psoriasis model." | 3.85 | Anti-Psoriasis Effects and Mechanisms of Α-(8-Quinolinoxy) Zinc Phthalocyanine-Mediated Photodynamic Therapy. ( Bao, J; Jiang, ZH; Jin, HT; Li, C; Li, WF; Liu, HQ; Wang, AP; Wang, YM; Wei, JF, 2017) |
| " The back of the ears of individual guinea pigs was topically exposed to 5% propranolol emulsion to induce psoriasis-like lesions and randomly treated topically with phosphate buffered saline (PBS), hydrocortisone butyrate, or different doses of anti-FGF10." | 3.80 | Topical application of a new monoclonal antibody against fibroblast growth factor 10 (FGF 10) mitigates propranolol-induced psoriasis-like lesions in guinea pigs. ( Dong, YY; Guan, LL; Li, HY; Li, XK; Liu, XM; Mmi, XG; Wang, FW; Wang, N; Wang, YF; Xia, JX; Yang, J; Yao, N, 2014) |
| "A 25-year-old male developed sinus tachycardia after given clozapine for treatment-resistant psychosis in schizophrenia." | 3.78 | [Treatment of clozapine-induced tachycardia with propranolol complicated by psoriasis]. ( Bosch, TM; Hovens, JE; Mookhoek, EJ; van Dam, D, 2012) |
| " Oral propranolol is currently the first choice in the treatment of alarming infantile hemangiomas." | 3.76 | Innovative therapeutics in pediatric dermatology. ( Frasin, A; Gelmetti, C; Restano, L, 2010) |
| "To investigate whether lithium carbonate, propranolol or chloroquine aggravate psoriasis through influencing cytokines of the psoriatic cytokine network, HaCaT keratinocytes were stimulated with TNF-a after treatment with these drugs." | 3.74 | [Effects of drugs known to trigger psoriasis on HaCaT keratinocytes]. ( Cen, JP; Cheng, H; Jin, N; Lin, AH; Zhu, KJ, 2007) |
| "All animals of group 2 (which received propranolol orally and in addition intradermal injections of adjuvant) developed psoriasiform epidermal hyperplasia with acanthosis." | 3.69 | Induction of psoriasiform changes in guinea pig skin by propranolol. ( Brenner, S; Shechter, H; Wolf, R, 1994) |
| " PHA-stimulated T cells were additionally treated with psoriasis-provoking drugs (lithium, chloroquine, propranolol and ethanol) and the two immunosuppressive drugs cyclosporin A and FK 506." | 3.69 | Tyrosine phosphorylation in psoriatic T cells is modulated by drugs that induce or improve psoriasis. ( Goos, M; Mertins, K; Nussbaum, G; Ockenfels, HM; Schultewolter, T; Wagner, SN, 1995) |
| "An 80-year-old man who had had plaque-type psoriasis for 40 years experienced a rapid onset of generalized pustular psoriasis three days after initiation of propranolol hydrochloride therapy." | 3.67 | Generalized pustular psoriasis provoked by propranolol. ( Farber, EM; Hu, CH; Miller, AC; Peppercorn, R, 1985) |
| "Quantitative measurements of eccrine sweat secretion following stimulation with adrenaline and terbutaline sulphate, a beta-stimulator, have been performed in patients with atopic dermatitis and psoriasis by means of the electrolytic water analyzer, "Meeco"." | 3.65 | Effects of adrenergic stimulating and blocking agents on the eccrine sweat secretion in atopic dermatitis and psoriasis. ( Kocsis, M; Thune, P, 1975) |
| "Congenital or atypical nevi of the child benefit from genetic progress or improvement of clinical knowledge." | 2.49 | [What’s new in pediatric dermatology?]. ( Lacour, JP, 2013) |
| "Psoriasis is a chronic inflammatory skin disease." | 1.32 | Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters. ( Joshi, R; Langguth, P; Merkle, HP; Werdenberg, D; Wolffram, S, 2003) |
| "Propranolol, 0." | 1.29 | Psoriasis-like lesions in guinea pigs receiving propranolol. ( Altug, T; Büyükdevrim, S; Gürel, N; Tüzün, B; Tüzün, Y; Tüzüner, N, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (57.14) | 18.7374 |
| 1990's | 6 (14.29) | 18.2507 |
| 2000's | 4 (9.52) | 29.6817 |
| 2010's | 7 (16.67) | 24.3611 |
| 2020's | 1 (2.38) | 2.80 |
| Authors | Studies |
|---|---|
| Li, JQ | 1 |
| Zhang, SH | 1 |
| Tong, RS | 1 |
| He, D | 1 |
| Zhong, ZD | 1 |
| She, SY | 1 |
| Yu, J | 2 |
| Xiao, Z | 2 |
| Zhao, R | 2 |
| Lu, C | 2 |
| Zhang, Y | 2 |
| Liu, HQ | 1 |
| Wang, YM | 1 |
| Li, WF | 1 |
| Li, C | 1 |
| Jiang, ZH | 1 |
| Bao, J | 1 |
| Wei, JF | 1 |
| Jin, HT | 1 |
| Wang, AP | 1 |
| Lacour, JP | 1 |
| Yao, N | 1 |
| Xia, JX | 1 |
| Liu, XM | 1 |
| Wang, N | 1 |
| Mmi, XG | 1 |
| Wang, YF | 1 |
| Guan, LL | 1 |
| Yang, J | 1 |
| Dong, YY | 1 |
| Wang, FW | 1 |
| Li, HY | 1 |
| Li, XK | 1 |
| Fraser, K | 1 |
| Ma, LJ | 1 |
| You, Y | 1 |
| Bai, BX | 1 |
| Li, YZ | 1 |
| Gelmetti, C | 1 |
| Frasin, A | 1 |
| Restano, L | 1 |
| van Dam, D | 1 |
| Bosch, TM | 1 |
| Mookhoek, EJ | 1 |
| Hovens, JE | 1 |
| Werdenberg, D | 1 |
| Joshi, R | 1 |
| Wolffram, S | 1 |
| Merkle, HP | 1 |
| Langguth, P | 1 |
| Cen, JP | 1 |
| Zhu, KJ | 1 |
| Jin, N | 1 |
| Lin, AH | 1 |
| Cheng, H | 1 |
| Voorhees, JJ | 3 |
| Duell, EA | 3 |
| Nemoto, O | 1 |
| Yoshikawa, K | 3 |
| Adachi, K | 3 |
| Takeda, J | 1 |
| Halprin, KM | 4 |
| Woodyard, CW | 1 |
| Levine, V | 3 |
| Pelkowitz, D | 1 |
| Wolf, R | 1 |
| Shechter, H | 1 |
| Brenner, S | 1 |
| Halevy, S | 3 |
| Livni, E | 2 |
| Tüzün, B | 2 |
| Tüzün, Y | 2 |
| Gürel, N | 1 |
| Tüzüner, N | 1 |
| Altug, T | 1 |
| Büyükdevrim, S | 1 |
| Ockenfels, HM | 1 |
| Nussbaum, G | 1 |
| Schultewolter, T | 1 |
| Mertins, K | 1 |
| Wagner, SN | 1 |
| Goos, M | 1 |
| Faure, M | 1 |
| Hermier, C | 1 |
| Perrot, H | 1 |
| Enger, E | 1 |
| Feuerman, EJ | 1 |
| Mui, MM | 1 |
| Hsia, SL | 1 |
| Mahrle, G | 2 |
| Orfanos, CE | 2 |
| Thune, P | 1 |
| Kocsis, M | 1 |
| Van de Kerkhof, P | 1 |
| Wiley, HE | 1 |
| Weinstein, GD | 1 |
| Gaylarde, PM | 1 |
| Brock, AP | 1 |
| Sarkany, I | 1 |
| Wadskov, S | 1 |
| Sondergaard, J | 1 |
| Mikkelsen, HI | 1 |
| Jensen, HE | 1 |
| Abel, EA | 1 |
| DiCicco, LM | 1 |
| Orenberg, EK | 1 |
| Fraki, JE | 1 |
| Farber, EM | 2 |
| Altomare, GF | 1 |
| Gandossi, E | 1 |
| Pigatto, PD | 1 |
| Polenghi, MM | 1 |
| Raznatovskiĭ, IM | 1 |
| Khvatov, EV | 1 |
| Egorov, VIa | 1 |
| Hu, CH | 1 |
| Miller, AC | 1 |
| Peppercorn, R | 1 |
| Stawiski, M | 1 |
| Harrell, ER | 2 |
| Bass, LJ | 1 |
| Powell, JA | 1 |
4 reviews available for propranolol and Palmoplantaris Pustulosis
| Article | Year |
|---|---|
[What’s new in pediatric dermatology?].
Topics: Adolescent; Child; Dermatitis, Atopic; Dermatology; Hemangioma, Capillary; Humans; Melanoma; Neoplas | 2013 |
"Psoriasis as a possible defect of the adenyl cyclase-cyclic AMP Cascade" by Voorhees and Duell, October 1971. Commentary: Cyclic adenosine monophosphate regulation of normal and psoriatic epidermis.
Topics: Adenylyl Cyclases; Arachidonic Acids; Calmodulin; Cell Division; Cyclic AMP; Cyclic GMP; Epidermis; | 1982 |
Drugs in exacerbation of psoriasis.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Anthralin; Anti-Inflammatory Agents, Non-Stero | 1986 |
Cyclic nucleotide metabolism in normal and proliferating epidermis.
Topics: Adenylyl Cyclases; Animals; Cell Differentiation; Cell Division; Cyclic AMP; Cyclic GMP; Glycogen; G | 1974 |
38 other studies available for propranolol and Palmoplantaris Pustulosis
| Article | Year |
|---|---|
Curcuma's extraction attenuates propranolol-induced psoriasis like in mice by inhibition of keratin, proliferating cell nuclear antigen and toll-like receptor expression.
Topics: Animals; Curcuma; Dermatologic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Epi | 2020 |
Paeoniflorin suppressed IL-22 via p38 MAPK pathway and exerts anti-psoriatic effect.
Topics: Animals; Blotting, Western; Cell Line; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Ge | 2017 |
Anti-Psoriasis Effects and Mechanisms of Α-(8-Quinolinoxy) Zinc Phthalocyanine-Mediated Photodynamic Therapy.
Topics: Aminoquinolines; Animals; Cell Line; Cell Proliferation; Disease Models, Animal; Epidermis; Epitheli | 2017 |
Astilbin emulsion improves guinea pig lesions in a psoriasis-like model by suppressing IL-6 and IL-22 via p38 MAPK.
Topics: Animals; Anti-Inflammatory Agents; Cell Line, Transformed; Disease Models, Animal; Ear; Emulsions; F | 2018 |
Topical application of a new monoclonal antibody against fibroblast growth factor 10 (FGF 10) mitigates propranolol-induced psoriasis-like lesions in guinea pigs.
Topics: Administration, Topical; Animals; Antibodies, Monoclonal; Cell Line; Cell Line, Tumor; Cell Prolifer | 2014 |
67th annual meeting of the American Academy of Dermatology: San Francisco, California, USA, 6-10 March 2009.
Topics: Acne Vulgaris; Dermatology; Hemangioma; Humans; Keratosis, Actinic; Melanoma; Methicillin-Resistant | 2009 |
Therapeutic effects of heme oxygenase-1 on psoriasiform skin lesions in guinea pigs.
Topics: Animals; Disease Models, Animal; Disease Progression; Enzyme Activation; Gene Expression Regulation; | 2009 |
Innovative therapeutics in pediatric dermatology.
Topics: Adolescent; Adrenal Cortex Hormones; Alopecia Areata; Autoimmune Diseases; Child; Child, Preschool; | 2010 |
[Treatment of clozapine-induced tachycardia with propranolol complicated by psoriasis].
Topics: Adrenergic beta-Antagonists; Adult; Antipsychotic Agents; Clozapine; Humans; Male; Propranolol; Psor | 2012 |
Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters.
Topics: Animals; Atenolol; Biological Availability; Caco-2 Cells; Cell Membrane Permeability; Cells, Culture | 2003 |
[Effects of drugs known to trigger psoriasis on HaCaT keratinocytes].
Topics: Adrenergic beta-Antagonists; Antimalarials; Cells, Cultured; Chloroquine; Humans; Interleukin-6; Int | 2007 |
Identification of a beta 2-adrenergic receptor in mammalian epidermis.
Topics: Albuterol; Animals; Butoxamine; Cyclic AMP; Epidermis; Humans; In Vitro Techniques; Isoproterenol; M | 1980 |
Measurement of adenosine 3',5'-monophosphate-dependent protein kinase and phosphorylase activities in in vivo conditions.
Topics: Animals; Cyclic AMP; Epidermis; Humans; Isoproterenol; Mice; Mice, Inbred BALB C; Phosphorylase a; P | 1982 |
A new treatment for psoriasis.
Topics: Drug Therapy, Combination; Humans; Propranolol; Psoriasis; Thyroxine | 1981 |
Induction of psoriasiform changes in guinea pig skin by propranolol.
Topics: Abscess; Administration, Oral; Alopecia; Animals; Disease Models, Animal; Epidermis; Female; Freund' | 1994 |
Beta-adrenergic blocking drugs and psoriasis: the role of an immunologic mechanism.
Topics: Cell Migration Inhibition; Drug Eruptions; Humans; Propranolol; Psoriasis | 1993 |
Psoriasis-like lesions in guinea pigs receiving propranolol.
Topics: Acanthosis Nigricans; Administration, Cutaneous; Animals; Drug Eruptions; Female; Guinea Pigs; Male; | 1993 |
Tyrosine phosphorylation in psoriatic T cells is modulated by drugs that induce or improve psoriasis.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Cells, Cultured; Chloroquine; Cyclosporine; Ethanol; | 1995 |
Experimental psoriasis models.
Topics: Animals; Disease Models, Animal; Guinea Pigs; Propranolol; Psoriasis; Rats; Species Specificity | 1997 |
[Cutaneous reactions to propranolol (author's transl)].
Topics: Adolescent; Adrenergic beta-Antagonists; Antibodies, Antinuclear; Drug Eruptions; Eczema; Humans; Lu | 1979 |
[Letter: Propranolol--psoriasiform eruption].
Topics: Drug Eruptions; Humans; Hypertension; Male; Middle Aged; Propranolol; Psoriasis | 1976 |
Psoriasiform eruption induced by propranolol.
Topics: Aged; Arrhythmias, Cardiac; Complement C3; Drug Eruptions; Fibrinogen; Humans; Immunoglobulin M; Mac | 1979 |
Further studies on adenyl cyclase in psoriasis.
Topics: Adenine; Adenosine Triphosphate; Adenylyl Cyclases; Cyclic AMP; Epinephrine; Humans; Kinetics; Propr | 1975 |
Prostaglandins and cyclic AMP in epidermis. Evidence for the independent action of prostaglandins and adrenaline on the adenyl cyclase system of pig and human epidermis, normal and psoriatic.
Topics: Adenylyl Cyclases; Animals; Binding Sites; Cyclic AMP; Epinephrine; Humans; In Vitro Techniques; Pro | 1975 |
On the lack of response to catecholamine stimulation by the adenyl cyclase system in psoriatic lesions.
Topics: Adenylyl Cyclases; Adult; Cyclic AMP; Epinephrine; Humans; In Vitro Techniques; Male; Propranolol; P | 1975 |
Ultrastructural localization and differentiation of membrane-bound ATP utilizing enzymes including adenyl cyclase in normal and psoriatic epidermis.
Topics: Adenosine Triphosphatases; Adenylyl Cyclases; Cell Membrane; Enzyme Activation; Glucagon; Glyceropho | 1975 |
Letter: Skin reactions to beta-blockers.
Topics: Adrenergic beta-Antagonists; Cross Reactions; Female; Humans; Middle Aged; Oxprenolol; Practolol; Pr | 1975 |
Effects of adrenergic stimulating and blocking agents on the eccrine sweat secretion in atopic dermatitis and psoriasis.
Topics: Adrenergic Agonists; Atropine; Dermatitis, Atopic; Eccrine Glands; Epinephrine; Humans; Isoprotereno | 1975 |
Psoriasiform changes in guinea-pig skin from propanalol.
Topics: Animals; Guinea Pigs; Propranolol; Psoriasis | 1979 |
Abnormal proliferation of uninvolved psoriatic epidermis: differential induction by saline, propranolol, and tape stripping in vivo.
Topics: Bandages; Cell Division; Humans; Propranolol; Psoriasis; Skin; Sodium Chloride | 1979 |
Psoriasiform changes in guinea-pig skin from propranolol.
Topics: Animals; Guinea Pigs; Propranolol; Psoriasis; Skin | 1978 |
[Lack of beta-adrenergic stimulation of membrane bound adenyl cyclase in psoriasis as compared to normal epidermis (author's transl)].
Topics: Adenylyl Cyclases; Cell Membrane; Enzyme Activation; Glucagon; Humans; In Vitro Techniques; Isoprote | 1975 |
[Psoriasis-like skin changes during treatment with propranolol (Inderal)].
Topics: Aged; Female; Humans; Hypertension; Male; Middle Aged; Propranolol; Psoriasis; Skin; Time Factors | 1976 |
Psoriasis and psoriasiform eruptions associated with propranolol--the role of an immunological mechanism.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Biopsy; Cell Movement; Child; Drug Hypersensiti | 1991 |
[Correlations between beta blockers and the induction of psoriasis].
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Humans; Male; Metoprolol; Middle Aged; Propranolol; Pso | 1987 |
[Blockade of adrenoreceptors--a mechanism for impairing the humoral and cellular regulation of the proliferation of epidermal cells in psoriasis].
Topics: Animals; Cell Division; Growth Inhibitors; Humans; Muscle Contraction; Muscle, Smooth, Vascular; Pro | 1988 |
Generalized pustular psoriasis provoked by propranolol.
Topics: Aged; Humans; Male; Methotrexate; Propranolol; Psoriasis; Skin Diseases, Vesiculobullous; Tremor | 1985 |
The cyclic AMP system in normal and psoriatic epidermis.
Topics: Adenylyl Cyclases; Cyclic AMP; Epinephrine; Glycogen; Histamine; Humans; Isoproterenol; Mitosis; Pho | 1972 |